<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Immunol</journal-id><journal-title>BMC Immunology</journal-title><issn pub-type="epub">1471-2172</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2172-3-11</article-id><article-id pub-id-type="pmid">12196270</article-id><article-id pub-id-type="doi">10.1186/1471-2172-3-11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1&#x003b1; by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Hofmann</surname><given-names>Nils</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>nils.hofmann@gmx.net</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Lachnit</surname><given-names>Nina</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ninalachnit@hotmail.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Streppel</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>michael.streppel@uni-koeln.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Witter</surname><given-names>Brigitte</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>brigitte.witter@uni-koeln.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Neiss</surname><given-names>Wolfram F</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>neiss.anatomie@uni-koeln.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Guntinas-Lichius</surname><given-names>Orlando</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>orlando.guntinas@uni-koeln.de</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Angelov</surname><given-names>Doychin N</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>angelov.anatomie@uni-koeln.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Institut f&#x000fc;r Anatomie der Universit&#x000e4;t zu K&#x000f6;ln, Germany</aff><aff id="I2"><label>2</label>Klinik f&#x000fc;r Hals-, Nasen- und Ohrenheilkunde der Universit&#x000e4;t zu K&#x000f6;ln, Germany</aff><pub-date pub-type="collection"><year>2002</year></pub-date><pub-date pub-type="epub"><day>26</day><month>8</month><year>2002</year></pub-date><volume>3</volume><fpage>11</fpage><lpage>11</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2172/3/11"/><history><date date-type="received"><day>19</day><month>4</month><year>2002</year></date><date date-type="accepted"><day>26</day><month>8</month><year>2002</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2002 Hofmann et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement><copyright-year>2002</copyright-year><copyright-holder>Hofmann et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder></permissions><abstract><sec><title>Background</title><p>T-cells extravasation and CNS parenchyma infiltration during autoimmune neurodegenerative disease can be evoked by local antigen presenting cells. Studying the chemoattracting potential of spinal perivascular macrophages (SPM) during experimental allergic encephalomyelitis (EAE), we observed numerous infiltrates of densely-packed mononuclear cells. Apart from the poor spatial and optical resolution, no differentiation between the resident SPM (mabs ED1<sup>+</sup>, ED2<sup>+</sup>) and the just recruited monocytes/macrophages (mab ED1<sup>+</sup>) was possible.</p></sec><sec><title>Results</title><p>This is why we labeled SPM by injections of different fluoresecent dyes into the lateral cerebral ventricle before induction of active EAE. Within an additional experimental set EAE was induced by an intraperitoneal injection of T-cells specifically sensitized to myelin basic protein (MBP) and engineered to express the green fluorescent protein (GFP). In both experiments we observed a strong activation of SPM (mabs OX6<sup>+</sup>, SILK6<sup>+</sup>, CD40<sup>+</sup>, CD80<sup>+</sup>, CD86<sup>+</sup>) which was accompanied by a consistently increased expression of ICAM-1, VCAM-1, and the chemokines MCP-1 and MIP-1&#x003b1;.</p></sec><sec><title>Conclusion</title><p>These observations indicate that SPM play a role in promoting lymphocyte extravasation.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Antigen specificity during an autoimmune attack is affected by antigen presentation and recognition, antigen expression and the response of target organs [<xref ref-type="bibr" rid="B1">1</xref>]. Accordingly, accumulating evidence shows that the extravasation of lymphocytes into the CNS perivascular (Virchow-Robin) space in the course of progressing autoimmune disease may be initiated by resident antigen presenting cells [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>].</p><p>It is generally acknowledged that, under conditions of a structurally intact blood-brain barrier, the cerebral/spinal perivascular macrophages (CPM/SPM) are the antigen presenting cells of the brain [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. CPM/SPM exhibit morphological features consistent with macrophages [<xref ref-type="bibr" rid="B10">10</xref>], express the scavenger receptor [<xref ref-type="bibr" rid="B8">8</xref>], the Major Histocompatibility Complex (MHC) class II glycoproteins on their surface [<xref ref-type="bibr" rid="B6">6</xref>], and act as scavengers in the cerebral blood-brain interface zone [<xref ref-type="bibr" rid="B11">11</xref>]. CPM/SPM retain the phagocytosed material and remain within the perivascular space for up to 2 years [<xref ref-type="bibr" rid="B11">11</xref>], with a rather slow turnover rate of about 6% per month [<xref ref-type="bibr" rid="B12">12</xref>]. Due to presence of Fc and complement receptors on their surface and expression of macrophage specific antigens [<xref ref-type="bibr" rid="B5">5</xref>], CPM/SPM are considered to be "the only macrophages found in the tissues of the CNS" [<xref ref-type="bibr" rid="B13">13</xref>].</p><p>CPM/SPM differ from pericytes with respect to their morphology and anatomic localization in the perivascular space [<xref ref-type="bibr" rid="B14">14</xref>]. Pericytes are &#x02013; like elsewhere in the body &#x02013; completely ensheathed by split layers of the vascular basal lamina and separated from the CNS tissue by the <italic>membrana limitans gliae perivascularis</italic>. CPM/SPM, on the contrary, are never enclosed within the basal lamina of the blood vessels. In this way, placed along the lymphatic drainage pathways of the brain, CPM/SPM are in a prime position not only for antigen presentation, but also for influencing endothelial cells and leukocyte migration from the blood [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>This is why we decided to study their role in experimental allergic encephalomyelitis (EAE), which is considered to represent an animal model for multiple sclerosis [<xref ref-type="bibr" rid="B16">16</xref>]. Our special interest was focused on the immunocytochemically detectable expression of cell adhesion molecules and chemokines by CPM/SPM.</p><p>Observation of spinal-cord sections from rats with EAE, however, revealed numerous densely-packed mononuclear cells in the Virchow-Robin space, which seriously jeopardized the imunocytochemical differentiation between the resident SPM (mab ED2<sup>+</sup>, mab ED1<sup>+</sup>) and the recently extravasated monocytes/macrophages (mab ED1<sup>+</sup>, mab ED2<sup>-</sup>) [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>].</p><p>To circumvent this poor spatial and optical resolution we labeled SPM by intracerebroventricular (<italic>icv</italic>) injections of different fluorescent dyes before induction of active EAE (injection with myelin basic protein in complete Freund's adjuvant). In additional experiments EAE was induced by the intraperitoneal injection of T-cells specifically primed to myelin basic protein (MBP) and engineered to express the green fluorescent protein (GFP) [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>].</p><p>In both sets of experiments we observed a strong activation of SPM (mabs OX6<sup>+</sup>, SILK6<sup>+</sup>, CD40<sup>+</sup>, CD80<sup>+</sup>, CD86<sup>+</sup>) which was accompanied by a consistently increased expression of ICAM-1, VCAM-1, and the chemokines MCP-1 and MIP-1&#x003b1;. We conclude that, indicating the sites for lymphocytic extravasation, SPM play an important role in the initiation of local inflammatory processes.</p></sec><sec><title>Results</title><sec><title>SPM in intact control animals</title><p>There was no diffuse staining indicative of free marker substance in the spinal cord of both rat strains after injection of horseradish peroxidase (HRP), Fluoro-Emerald (FE), or Fluoro-Ruby (FR) in the right lateral ventricle: only the perivascular macrophages were labeled (<italic>arrows</italic> in Fig. <xref ref-type="fig" rid="F1">1</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Labeling of spinal perivascular macrophages (SPM) after <italic>icv</italic> injection of horseradish peroxidase (HRP) and Fluoro-Emerald (FE). Longitudinal section through the lumbar spinal cord of intact control animals showing SPM (<italic>arrows</italic>) labeled by HRP <bold>(A)</bold> and by FE <bold>(B)</bold>. 50 &#x003bc;m thick vibratome sections.</p></caption><graphic xlink:href="1471-2172-3-11-1"/></fig></sec><sec><title>SPM in rats with active EAE at the peak of paraparesis</title><p>The SPM-labeling turned out to be extremely irregular after <italic>icv</italic> injection of any label in LEW/Han Rij Hsd rats at the peak of EAE (severe paraparesis). In 11 out of 21 paraplegic animals we found no labeling in the spinal cord 24 hours after icv application (Fig. <xref ref-type="fig" rid="F2">2A</xref>). Since tracers could be detected in the brain parenchyma around the injection site, we attributed their lack in the lumbar spinal cord to a blockade of the cerebrospinal-fluid circulation by the inflammatory oedema.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Labeling of spinal perivascular macrophages (SPM) after <italic>icv</italic> injection of HRP in rats with EAE. <bold>A:</bold> Spinal cord of a rat with a severe paraparesis showing large erythrocytic infiltrates but no labeling of SPM; 50 &#x003bc;m vibratome section. <bold>B:</bold> The successful HRP-DAB labeling of SPM (<italic>arrows</italic>) in rats with EAE reveals more labeled SPM than in normal control animals; 50 &#x003bc;m vibratome section. <bold>C:</bold> The dense perivascular leukocytic infiltrates in the spinal cord parenchyma of rats with severe paraparesis allow only poor spatial resolution between the endothelial and extravasated cells in 50 &#x003bc;m thick vibratome sections. <bold>D:</bold> No differentiation among the various types of extravasated cells filling the periavscular space was possible also in plastic semithin sections (0.5 &#x003bc;m thick) counterstained with toluidine blue. <bold>E:</bold> Rat with severe paraparesis. Electron micrograph showing a HRP-labeled SPM with vacuolated cytoplasm. Counterstaining with uranyl acetate and lead citrate.</p></caption><graphic xlink:href="1471-2172-3-11-2"/></fig><p>Observation of vibratome sections from the other 10 paraplegic rats revealed successful intensive labeling of the perivascular macrophages in both brain as well as spinal cord (<italic>arrows</italic> in Fig. <xref ref-type="fig" rid="F2">2B</xref>). Obviously in these animals the CSF-circulation was not so strongly affected by the inflammatory oedema.</p><p>Unfortunately these sections failed to provide clearcut information about the relationship between SPM and lymphocytes during extravasation. The presence of well-advanced lymphocytic infiltrates in the spinal cord parenchyma indicated that the extravasation had already occurred. No spatial resolution of the various cellular elements within these "perivascular cuffs" by conventional microscopy was possible (Fig. <xref ref-type="fig" rid="F2">2C, 2D</xref>). The electron microscopic analysis showed that a large portion of the HRP-labeled SPM contained shrunken nuclei and vacuolated scanty cytoplasm, i.e. displayed signs of degeneration (Fig. <xref ref-type="fig" rid="F2">2E</xref>).</p></sec><sec><title>SPM in rats with transfer EAE at the peak of paraparesis</title><p>Following injection of T<sub>MBP</sub>GFP cells the syngenic LEW/CRL BR rats developed the typical monophasic course of EAE. The peak of paraparesis and incontinence was observed 5 days after injection of T<sub>MBP</sub>GFP cells. The histological examination at this period revealed a massive infiltration of the CNS with green fluorescent mononuclear cells (Fig. <xref ref-type="fig" rid="F3">3A, 3B</xref>). Their density was extremely irregular. Injection of 5% FR at the peak of paraparesis into the lateral ventricle labeled the SPM in red (Fig. <xref ref-type="fig" rid="F3">3B</xref>) and allowed unbiased observations of the relationship between SPM and infiltrating lymphocytes.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>Vibratome section from the lumbar spinal cord of a rat in which EAE was induced by an intraperitoneal injection of 5 &#x000d7; 10<sup>6</sup> T<sub>MBP</sub>GFP cells. <bold>A:</bold> Five days post application (peak of paraparesis) the green fluorescent autoaggressive T-lymphocytes (<italic>empty arrows</italic>) have infiltrated both white and grey matter. <bold>B:</bold> The assumption that the bulk of T<sub>MBP</sub>GFP cells would stay in contact with the red (FR-labeled) SPM (<italic>arrows</italic>) was wrong: most lymphocytes succeeded to find a way towards the CNS parenchyma.</p></caption><graphic xlink:href="1471-2172-3-11-3"/></fig><p>These new data falsified one expectation that had been based on earlier work. Our hypothesis, that most (if not all) of the red-fluorescent SPM would be approached and contacted by the extravasated autoagressive lymphocytes, turned out to be wrong. Despite a general impression that some T<sub>MBP</sub>GFP cells adhered to SPM, most lymphocytes found a way into the CNS parenchyma through the walls of capillaries and venules which do not possess a SPM lining.</p><p>Thus, the invasion of leukocytes (non-labeled as well as T<sub>MBP</sub>GFP cells) occurred despite the barrier role of SPM to CNS infiltration which we had previously shown in a different kind of experiment [<xref ref-type="bibr" rid="B4">4</xref>]. Being a component of a neuroprotective mechanism of extraparenchymal antigen presentation and prevention of infiltrates, activated SPM can impede blood cells from crossing the lamina superficialis gliae limitans and infiltrate CNS parenchyma <italic>under conditions of a non-inflammatory immune response to exogenous proteins</italic>[<xref ref-type="bibr" rid="B4">4</xref>]. During EAE, however, SPM fail to stop the infiltration of CNS parenchyma by highly activated lymphocytes (primed against MBP). Obviously the degree of T cell activation, the number of activated T cells, and the localization of the target antigen in the CNS are all important factors in determining the extent of intraparenchymal T cell infiltration.</p></sec><sec><title>Immunlogical pertinence of the non-phagocytic cells</title><p>Many non-phagocytic cells in the spinal perivascular space, which were not labeled by the <italic>icv</italic> applied fluorescent dyes, could be stained by the lymphocyte-recognizing antibodies R73, W3/25, and OX-50 (data not shown; see however Fig. <xref ref-type="fig" rid="F4">4</xref> in Walther et al., 2001) [<xref ref-type="bibr" rid="B4">4</xref>].</p><fig position="float" id="F4"><label>Figure 4</label><caption><p>Activation of SPM in 50 &#x003bc;m vibratome sections from the spinal cord of rats with severe EAE. All cells which have been labeled by <italic>icv</italic> application of FE (<italic>green</italic> in <bold>A,C,E</bold>) are ED2-positive (<bold>B</bold>), OX6-positive (<bold>D</bold>), SILK6-positive (<bold>F</bold>). <bold>G, H:</bold> Almost all FE-labeled SPM express the CD40 molecule (CY3). <bold>I, J, K, L:</bold> FE-labeled SPM (<bold>I, K</bold>) express also the B7-1 (<bold>J</bold>) and the B7-2 (<bold>L</bold>) molecule as detected by immunofluorescence with anti-CD80, anti-CD86, and CY3.</p></caption><graphic xlink:href="1471-2172-3-11-4"/></fig></sec><sec><title>Activation of SPM during EAE</title><p>Estimating the degree of activation of SPM during EAE, we found that the bulk of SPM, which were labeled and thus identified by by <italic>icv</italic> injection with FE (Fig. <xref ref-type="fig" rid="F4">4A,4C,4E,4G,4I,4K</xref>) were ED2-positive [<xref ref-type="bibr" rid="B20">20</xref>], expressed MHC class II glycoproteins, IL1-&#x003b2;, CD40-, and B7-molecules (Figs. <xref ref-type="fig" rid="F4">4B,4D,4F,4H,4J,4L</xref>). Whereas the immunoreactivity for both the ED2-antigen and MHC class II glycoproteins is constitutive and thus present also in unaffected rats, there was no staining of SPM in spinal cord sections from intact rats after incubation with SILK6, anti-CD40, anti-CD80, anti-CD86 (data not shown; see however the right column of Fig. <xref ref-type="fig" rid="F3">3</xref> in Walther et al., 2001) [<xref ref-type="bibr" rid="B4">4</xref>].</p></sec><sec><title>Expression of cell adhesion molecules by SPM during EAE</title><p>To elucidate the putative chemoattracting potential of SPM, which were labeled green by an <italic>icv</italic> injection of FE, we investigated whether they expressed molecules promoting extravasation of leukocytes. Despite the common view that during ongoing inflammation the expression of adhesion molecules by the cerebral endothelium is not sufficient to support leukocyte recruitment [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>], we compared the expression of cell adhesion molecules between unaffected rats and animals with EAE. Following incubation with polyclonal anti-<italic>ICAM-1</italic> and anti-<italic>VCAM-1</italic> and visualization of the immunoreaction product by the red fluorescence of Cy3, we observed much more immunopositive SPM (orange-yellow fluorescence) in the paraplegic rats (Fig. <xref ref-type="fig" rid="F5">5A,5C</xref>) than in the intact controls (Fig. <xref ref-type="fig" rid="F5">5B,5D</xref>). Although the numerous and densely-packed cells in and around the Virchow-Robin space rendered difficult the discrimination between endothelial cells, recruited macrophages and activated SPM, these results are in line with the earlier findings demonstrating expression of VCAM-1 mRNA in cerebral perivascular macrophages in the acute phase of immune-mediated injury [<xref ref-type="bibr" rid="B24">24</xref>].</p><fig position="float" id="F5"><label>Figure 5</label><caption><p>Expression of cell adhesion molecules and chemokines as revealed by double exposure pictures taken from in the lumbar spinal cord of animals with EAE (<bold>A, C, E, G</bold>) and in intact rats (<bold>B, D, F, H</bold>). SPM have been labeled and identified by <italic>icv</italic> injection of 5% FE and fluoresce in green. The reaction product expressed by SPM has been visualized by FluoroLink&#x02122; Cy3&#x02122;-Streptavidin, which yields an orange-yellow fluorescence from the immunopositive SPM.</p></caption><graphic xlink:href="1471-2172-3-11-5"/></fig></sec><sec><title>Production of chemokines by SPM during EAE</title><p>Chemokines are proposed to play a role in CNS inflammatory disease at the stage of leukocyte recruitment in the perivascular space in response to activated antigen-specific T-lymphocytes [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Together with their receptors the chemokines build a complex and sophisticated biochemical signaling system involved in the regulation of leukocyte and lymphocyte trafficking [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Both, adhesion molecule expression as well as production of chemokines within the CNS have been reported (reviewed in Prat et al., 2001) [<xref ref-type="bibr" rid="B29">29</xref>]. However, sound morphological evidence elucidating mechanism(s) by which precisely identified SPM (but not perivascular glial cells or perivascular astrocytes) could promote extravasation of leukocytes into the Virchow-Robin space and thus initiate inflammatory relapses, is still missing.</p><p>The chemokines <italic>MCP-1</italic> (monocyte chemoattractant protein) and MIP-1&#x003b1; (macrophage inflammatory protein 1&#x003b1;) are known to play crucial roles in recruiting macrophages and monocytes [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. Using monoclonal mouse antibodies we observed more MCP-1 and MIP-1&#x003b1; positive SPM (Fig. <xref ref-type="fig" rid="F5">5E,5G</xref>) in animals with EAE than in intact control rats (Fig. <xref ref-type="fig" rid="F5">5F,5H</xref>).</p></sec></sec><sec><title>Discussion</title><sec><title>Clinical importance of T-cell extravasation</title><p>A major issue in the pathogenesis of any autoimmune neurological disease is <italic>how</italic> autologous proteins, that had been pathologically altered "behind" an intact blood-brain barrier (BBB) can mediate T-lymphocyte entry into the central nervous system (CNS) and trigger inflammatory relapses [<xref ref-type="bibr" rid="B33">33</xref>]. These relapses consist of (i) early proinflammatory response, (ii) recruitment of antigen specific T-lymphocytes, and (iii) invasion of leukocytes (monocytes/macrophages, T- and B-lymphocytes) into the brain parenchyma [<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B38">38</xref>].</p><p>The last process listed, i.e. the accumulation of immune effectors around the cerebral microvasculature ("perivascular lymphocytic cuffs") is considered to initiate or exacerbate an inflammatory process, which is accompanied by a localized breakdown of the blood-brain barrier to serum proteins, leading to focal oedema [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. The "bystander demyelination" [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>], together with the subsequent interruption of axons [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>], provide the pathologic correlate of irreversible neurologic impairment [<xref ref-type="bibr" rid="B45">45</xref>].</p><p>In contrast, the molecular mechanisms which rule the first two processes, i.e. the proinflammatory response and the subsequent CNS-recruitment of T-lymphocytes, remain unclear. This lack of sound knowledge is very disappointing because in the course of many immune-mediated diseases such as multiple sclerosis, postinfectious encephalomyelitis, viral encephalitis, the entry of T-lymphocytes into the CNS is one of the earliest events in their pathogenesis [<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B48">48</xref>]. Morphologically, T-lymphocytes have been shown to cross the BBB via a transendothelial route, preferentially in parajunctional areas of endothelial cells [<xref ref-type="bibr" rid="B49">49</xref>]. Interestingly, there appears to be a particularly high density of endothelial adhesion molecule expression in these areas [<xref ref-type="bibr" rid="B50">50</xref>]. Although the large number of T-lymphocytes seen in specific regions or plaques in the acute stage of multiple sclerosis suggests that there is specific targeting in the immune response [<xref ref-type="bibr" rid="B15">15</xref>], the basic mechanisms ruling the extravasation of lymphocytes into the perivascular (Virchow-Robin) space and the subsequent infiltration of the brain-parenchyma have not been entirely elucidated yet.</p></sec><sec><title>Possible role of T-cell receptors (TCR)</title><p>The generally accepted current theory is based on the fact that CNS is continuously patrolled by activated T-lymphocytes [<xref ref-type="bibr" rid="B49">49</xref>-<xref ref-type="bibr" rid="B51">51</xref>]. Upon antigenic stimulation to a blast phase [<xref ref-type="bibr" rid="B52">52</xref>] these lymphocytes which carry T cell receptors (TCR) for CNS autoantigens initiate an "encephalitogenic immune response", i.e. if these "antigen seeking" T-cells encounter their antigen in the CNS [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B52">52</xref>-<xref ref-type="bibr" rid="B54">54</xref>] they could promote an inflammatory reaction through the secretion of pro-inflammatory cytokines [<xref ref-type="bibr" rid="B55">55</xref>-<xref ref-type="bibr" rid="B58">58</xref>]. This leads to the upregulation of endothelial adhesion molecules and the local production of chemokines, which in concert facilitate the entry of circulating B- and T-lymphocytes [<xref ref-type="bibr" rid="B59">59</xref>] and inflammatory effector cells into the local lesion sites [<xref ref-type="bibr" rid="B60">60</xref>]. This "direct" or "chemotaxis-based" theory of extravasation and infiltration acknowledges the "site-specific lymphocyte entry" as a key event for the progression of disease and outcome [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B61">61</xref>-<xref ref-type="bibr" rid="B63">63</xref>].</p></sec><sec><title>Possible role(s) of the resident antigen presenting cells</title><p>Since, however, the inflammation-triggering antigen recognition by T-lymphocytes can take place only after presentation of antigen in association with the MHC class II molecule, the role of the resident antigen presenting cells (APC) during lymphocyte extravasation is a matter of continuously expanding interest [<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B64">64</xref>-<xref ref-type="bibr" rid="B67">67</xref>]. Earlier work has shown that the most probable candidate for antigen presentation within the rat CNS are the ED2-positive CPM/SPM [reviewed in [<xref ref-type="bibr" rid="B68">68</xref>]].</p><p>Due to their strategic location distal to the blood-endothelial interface and proximal to the glia limitans, CPM/SPM are able to phagocytize neuronal debris in the cerebral interstitium and to contact extravasated T-lymphocytes [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B69">69</xref>]. CPM/SPM synthesize MHC class II glycoproteins constitutively and, following neuronal death, transform into IL-1&#x003b2; secreting neuronophages [<xref ref-type="bibr" rid="B70">70</xref>,<xref ref-type="bibr" rid="B71">71</xref>]. Recent evidence also implicates SPM as primary targets of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection in the CNS of humans and macaques [<xref ref-type="bibr" rid="B72">72</xref>]. Anyway, these cells must not be mixed up with other "sentinels" of the immune system within the brain, e.g. the ED2-negative dendritic cells in the meninges and choroid plexus [<xref ref-type="bibr" rid="B73">73</xref>].</p><p>Accordingly, current knowledge shows that since the synthesis of T-cell receptors (TCR) is directly dependent on the concentration of MHC class II peptides expressed by APC [<xref ref-type="bibr" rid="B74">74</xref>], the latter are able to mediate the trafficking of specific antigen-primed T-lymphocytes [<xref ref-type="bibr" rid="B75">75</xref>] or B-lymphocytes [<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>] into the cerebral area. Thus, the capacity to activate lymphocytes for transfer of severe experimental autoimmune encephalomyelitis has been attributed to cerebral APC [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B78">78</xref>]. Furthermore, activating memory/blast CD4<sup>+</sup> T-lymphocytes through secretion of cytokines [<xref ref-type="bibr" rid="B79">79</xref>,<xref ref-type="bibr" rid="B80">80</xref>] and co-stimulatory molecules, APC could play a key role in the repetitive lymphocytic invasions and leukocyte recruitment [<xref ref-type="bibr" rid="B81">81</xref>-<xref ref-type="bibr" rid="B83">83</xref>]. Finally, selective depletion of blood-borne or resident perivascular macrophages during EAE causes suppression of clinical symptoms [<xref ref-type="bibr" rid="B84">84</xref>-<xref ref-type="bibr" rid="B89">89</xref>].</p></sec></sec><sec><title>Conclusions</title><p>In the present study we used a combination of a technique for invasive, but very reliable labeling of SPM plus an immunocytochemcal analysis of their activity status. Studying the reactivity of identified SPM in very small details, this report provides evidence for increased expression of cell adhesion molecules (ICAM-1, VCAM-1) and intensified production of chemokines (MCP-1, MIP-1&#x003b1;) by SPM during EAE. Since these findings, which could enhance T-cell extravasation, were observed in both "antigen-induced or active" and "T cell transfer-induced" forms of EAE, we suppose that they reflect a common neurobiological response of antigen-presenting SPM upon interaction with primed T-lymphocytes.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Animals</title><p>Young adult (3 months of age) male Lewis rats were used: Twenty-six animals were from the strain LEW/Han Rij Hsd (purchased from Harlan Winkelmann, D-33176 Borchen, Germany) and 16 rats from the strain LEW/CRL BR (purchased from Charles River Deutschland, D-97633 Sulzfeld, Germany). Before and after experiments all rats were kept on standard laboratory food and tap water <italic>ad libitum</italic> with an artificial light-dark cycle of 12 hours light on, 12 hours light off. All experiments were conducted in accordance with the German law on Animal Protection and all procedures were approved by the Local Animal-Protection Committe (Bezirksregierung K&#x000f6;ln, Az. 23.203.2-K 35, 33/98).</p></sec><sec><title>Overview of experiments</title><p>Sixteen LEW/Han Rij Hsd animals comprised the <bold>intact control group</bold> and were used to optimize the labeling of spinal perivascular macrophages (SPM) by intracerebroventricular (<italic>icv</italic>) injections of horseradish peroxidase (HRP; 4 rats) or fluorochrome-conjugated dextrans (4 rats). Other 8 rats were used to immunocytochemically demonstrate the basic expression of molecules promoting SPM activation and lymphocyte extravasation.</p><p>The <bold>antigen-induced EAE (active EAE) group</bold> consisted of 10 rats which were used to immunocytochemically demonstrate the reactive changes in SPM during EAE.</p><p>The <bold>T cell transfer-induced EAE (transfer EAE) group</bold> consisted of 16 LEW/CRL BR rats. Eight animals were used as intact controls. The other 8 rats received an intraperitoneal injection of 5 &#x000d7; 10<sup>6</sup> autoaggressive MBP-specific T-lymphocytes in 3 ml 10% FCS-containing medium. Since these cells had been genetically engineered to express the green fluorescent protein (GFP), they were readily detectable within the heterogenous perivascular infiltrates ("cuffs") in the spinal cord of rats with EAE [<xref ref-type="bibr" rid="B18">18</xref>]. A preceeding labeling of the SPM in red fluorescence (Fluoro-Ruby) revealed the complex relationships between the resident SPM and the extravasated GFP-transduced, MBP-specific (T<sub>MBP</sub>GFP) lymphocytes.</p></sec><sec><title>Labeling of SPM employing intracerebroventricular (icv) injections</title><p>After an intraperitoneal injection of Ketamin plus Xylazin (100 mg Ketanest<sup>&#x000ae;</sup> plus 5 mg Rompun<sup>&#x000ae;</sup> per kg body weight) the rats were fixed in a stereotactic apparatus and received 35 &#x003bc;l of a 5% solution of horseradish peroxidase (HRP, Type VIA, Sigma, No. P 6782), fluorescein-dextran (Fluoro-Emerald, FE; Molecular Probes, Cat. No. D-1820) or rhodamine-dextran (Fluoro-Ruby, FR; Molecular Probes D-1817) in 0.9% NaCl saline into the right lateral cerebral ventricle. All solutions were injected over a period of 5 min [<xref ref-type="bibr" rid="B90">90</xref>] using a very thin (10 &#x003bc;m thick) glass pipette to minimize tissue damage [<xref ref-type="bibr" rid="B91">91</xref>].</p></sec><sec><title>Induction of experimental allergic encephalomyelitis (EAE)</title><p>EAE was induced in 37 LEW/Han Rij Hsd rats by a single intradermal (hind footpad) injection containing 25 &#x003bc;g myelin basic protein from guinea pig (MBP; Sigma M2295), 100 &#x003bc;g Mycobacterium tuberculosis H37 RA (Difco Laboratories, Cat. Nr. 3114-33-8) in 50 &#x003bc;l Complete Freund's Adjuvant (CFA; Difco Laboratories, Cat. Nr. 0638-60-7).</p></sec><sec><title>Tissue processing</title><sec><title>Fixation</title><p>All rats were anesthetized with ether, their vascular system rinsed for 60 sec with 0.9% NaCl saline and fixed for at least 40 min by transcardial perfusion with 1.0 litre of periodate-lysine-paraformaldehyde (PLP) fixative [<xref ref-type="bibr" rid="B92">92</xref>]. The PLP fixative was separately mixed from premade stem stock solutions immediately prior to the perfusion of each animal. The CNS (cerebrum, cerebellum, brainstem, spinal cord) was removed and stored in a 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer, pH 7,4.</p></sec><sec><title>Visualizing of HRP-labeled SPM</title><p>In contrast to our previous work [<xref ref-type="bibr" rid="B4">4</xref>] we focused our observations on the lumbar spinal cord only: Since the major visible symptom during EAE is the severe paraparesis of the hind limbs, most of the pathological alterations should be expected, localized and observed in this region. Longitudinal vibratome sections (50 &#x003bc;m thick) of the spinal cord were incubated for 20 min in 0.75% (w/v) 3,3'-diaminobenzidine tetrahydrochloride (150 mg in 200 ml buffer; DAB, Sigma, D 5637) plus 0.01% (v/v) H<sub>2</sub>O<sub>2</sub> plus 0.075% (w/v) nickel chloride in 0.05 M Tris-HCl buffer, pH 7.6. This procedure yielded a very intensive dark-purple to black reaction product exclusively in the cytoplasm of the SPM. Control tissue (sections from brains which had not received HRP injections) contained no reaction product. For electron microscopy some of the sections were postfixed in 1% OsO<sub>4</sub> + 1.5% K<sub>3</sub><sup>III</sup>Fe(CN)<sub>6</sub>[<xref ref-type="bibr" rid="B93">93</xref>], dehydrated in graded acetones, and embedded flat in Araldite CY212 (Fluka, No. 44610).</p></sec><sec><title>Visualizing of FE- and FR-labeled SPM</title><p>To detect the green fluorescence of FE or the red fluorescence of FR vibratome sections (50 &#x003bc;m thick) of the spinal cord were illuminated through filter set 10 (excitation BP 450-490, beamsplitter FT 510, emission BP 515-565) or filter set 15 (Excitation BP 546/12, Emission LP 590) of a Carl Zeiss microscope.</p></sec></sec><sec><title>Immunocytochemistry</title><sec><title>Primary antibodies</title><p>(1) Mouse monoclonal OX-6 (Serotec, MCA 46, 1:1000) recognizing rat MHC class II (Ia) antigen. (2) Mouse monoclonal SILK 6 (Serotec, MCA-1397, 1:500) recognizing recombinant rat IL-1&#x003b2;. (3) Armenian hamster monoclonal anti-mouse CD40 (BD PharMingen, 09401A, 1:100) to test for presence of the costimulatory molecule CD40 on SPM. (4) Mouse monoclonal CD80 (BD PharMingen, 22661D, 1:100) to test for presence of the co-stimulatory molecule B7-1 on rat SPM. (5) Mouse monoclonal CD86 (BD PharMingen, 22671D, 1:100) to test for presence of the co-stimulatory molecule B7-2 on rat SPM. (6) Monoclonal mouse anti-rat TCR alpha/beta (clone R73, Serotec MCA 453G, 1:20) recognizing a constant determinant of the &#x003b1;/&#x003b2; T cell receptor. (7) Monoclonal mouse anti-rat CD4 (clone number W3/25, Serotec MCA55G, 1:50) recognizing the CD4 cell surface glycoprotein expressed by helper T cells and thymocytes. (8) Monoclonal mouse anti-rat CD44 (clone OX-50, Serotec MCA643XZ, 1:50) recognizing the CD44 cell surface antigen expressed by T cells, B cells, macrophages, and thymocytes. (9) Polyclonal goat anti-rat ICAM-1(M-19; Santa Cruz Biotechnology Inc., sc-1511, 1:50) recognizing rat intercellular adhesion molecule-1. (10) Polyclonal goat anti-rat VCAM-1(C-19; Santa Cruz Biotechnology Inc., sc-1504, 1:50) recognizing rat vascular cell adhesion molecule-1. (11) Polyclonal rabbit anti-rat MCP-1 (Cedarlane, No. CL9576AP, 1:500). recognizing the CC-chemokine "monocyte chemoattractant protein-1" which promotes the directed migration of inflammatory cells. (12) Polyclonal rabbit anti-rat MIP-1&#x003b1; (Cedarlane, No. CL9577AP, 1:2000) recognizing the chemokine "macrophage inflammatory protein-1&#x003b1; ".</p></sec><sec><title>Secondary antibodies</title><p>(1) Biotinylated goat anti-rabbit IgG (DAKO, No. E0432). (2) Biotinylated goat anti-mouse IgG (Fab-specific, Sigma, B-0529). (3) Biotinylated goat anti-mouse IgG (Fc specific, pre-absorbed with human IgG and rat serum proteins, Sigma, No. B-9904). (4) Biotinylated rabbit anti-goat IgG (DAKO, No. E0466). In order to minimize the background staining of neurons the biotinylated IgGs were always pre-absorbed with the individual rat's spleen protein [<xref ref-type="bibr" rid="B70">70</xref>]. (5) Biotin-conjugated mouse anti-hamster IgG (cocktail; PharMingen, 12102D).</p></sec><sec><title>Standard incubation protocol</title><p>Free floating vibratome sections were immunostained on a shaker at room temperature through the following steps: (1) 0.6% (v/v) H<sub>2</sub>O<sub>2</sub> in buffer (to block the endogenous peroxidase activity) for 30 min; (2) 5.0% (w/v) bovine serum albumin (BSA, Sigma No. A-9647) in 0.1 M Tris-buffered saline (TBS) pH 7.6 for 60 min; (3) primary antibody (see above) diluted in TBS plus 0.8% (w/v) BSA for 2 h; (4) 5.0% (v/v) normal goat serum (NGS, Vector No. S-1000) or normal rabbit serum (NRS, DAKO, No. X0902) plus 0.8% BSA in TBS for 15 min. (5) 1:400 dilution of the corresponding biotinylated secondary antibody in TBS for 1 h; (6) 1:100 diluted FluoroLink&#x02122; Cy2&#x02122;-Streptavidin (Amersham Life Science, PA 42001) or FluoroLink&#x02122; Cy3&#x02122;-Streptavidin (Amersham Life Science, PA 43001) for 1 h. Steps (1) and (5) were followed by two 10 min washes in TBS. Steps (3) and (6) were followed by four 10 min washes in TBS. Finally, sections were dehydrated with ethanol and Histoclear (a nontoxic xylene-substitute) and coverslipped.</p></sec><sec><title>Controls</title><p>Omission of the primary or secondary antibody yielded blank sections in which only the green SPM fluoresced. Incubation of sections with non-relevant biotinylated secondary antibodies (e.g. goat anti-rabbit IgG for recognition of mouse primary antibodies) yielded also blank sections.</p></sec><sec><title>Fluorescence microscopy</title><p>FE-labeled SPM and Cy2-immunopositive cells were visualized through filter set 10 of a Carl Zeiss fluorescence microscope. FR-labeled SPM and Cy3-immunopositive cells were observed through Zeiss filter set 15 (excitation BP546/12, beamsplitter FT580, emission LP590). Both FE-labeled SPM and CY3-immunopositive cells could be simultaneously observed employing Zeiss filter set 25 (excitation TBP400/495/570, beamsplitter FT410/505/585, emission TBP460/530/610).</p></sec></sec></sec><sec><title>Authors' contributions</title><p>N.H. participated in the <italic>icv</italic> labelings and counts of the SPP. N.L. performed the immunocytochemistry. M.S. participated in the icv labelings. B.W. performed the intraperitoneal injections of T<sub>MBP</sub>GFP lymphocytes. W.F.N. participated in the coordination of the study. O.G.L. participated in the icv labelings. D.N.A. designed the study, induced EAE, participated in the <italic>icv</italic> labelings and perfused the animals.</p><p>All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work has been financially supported by the Imhoff-Foundation (D.N.A.), the Jean Uhrmacher-Foundation (O.G.-L.), and the Megapharm GmbH, Germany (M.S.). The authors are thankful to Dr. Alexander Fl&#x000fc;gel (Max-Planck-Institut f&#x000fc;r Neurobiologie, Martinsried, Germany) for the generously provided T<sub>MBP</sub>GFP cells. The skillful technical assistance of Mrs. Ilona Rohrmann and Mrs. Dirkje Felder and the fine photographical work of Mrs. Inge Koch are highly appreciated.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marrack</surname><given-names>P</given-names></name><name><surname>Kappler</surname><given-names>J</given-names></name><name><surname>Kotzin</surname><given-names>B</given-names></name></person-group><article-title>Autoimmune disease:why and where it occurs.</article-title><source>Nature Medicine</source><year>2001</year><volume>7</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">11479621</pub-id><pub-id pub-id-type="doi">10.1038/90935</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>VH</given-names></name></person-group><article-title>A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation.</article-title><source>J Neuroimmunol</source><year>1998</year><volume>90</volume><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">9817438</pub-id><pub-id pub-id-type="doi">10.1016/S0165-5728(98)00145-3</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Archelos</surname><given-names>JJ</given-names></name><name><surname>Hartung</surname><given-names>H-P</given-names></name></person-group><article-title>Pathogenetic role of autoantibodies in neurological disease.</article-title><source>TINS</source><year>2000</year><volume>23</volume><fpage>317</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">10856942</pub-id><pub-id pub-id-type="doi">10.1016/S0166-2236(00)01575-7</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Popratiloff</surname><given-names>AS</given-names></name><name><surname>Lachnit</surname><given-names>N</given-names></name><name><surname>Hofmann</surname><given-names>N</given-names></name><name><surname>Streppel</surname><given-names>M</given-names></name><name><surname>Guntinas-Lichius</surname><given-names>O</given-names></name><name><surname>Neiss</surname><given-names>WF</given-names></name><name><surname>Angelov</surname><given-names>DN</given-names></name></person-group><article-title>Exogenous antigen containing perivascular phagocytes induce a non-encephalitogenic extravasation of primed lymphocytes.</article-title><source>J Neuroimmunol</source><year>2001</year><volume>117</volume><fpage>30</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">11431002</pub-id><pub-id pub-id-type="doi">10.1016/S0165-5728(01)00302-2</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>WF</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Perivascular microglial cells of the CNS are bone marrow derived and present antigen in vivo.</article-title><source>Science</source><year>1988</year><volume>239</volume><fpage>290</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">3276004</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graeber</surname><given-names>MB</given-names></name><name><surname>Streit</surname><given-names>WJ</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name></person-group><article-title>Identity of ED2-positive perivascular cells in rat brain.</article-title><source>J Neurosci Res</source><year>1989</year><volume>22</volume><fpage>103</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">2926837</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graeber</surname><given-names>MB</given-names></name><name><surname>Streit</surname><given-names>WJ</given-names></name><name><surname>B&#x000fc;ringer</surname><given-names>D</given-names></name><name><surname>Larry Sparks</surname><given-names>D</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name></person-group><article-title>Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain</article-title><source>J Neuropathol</source><year>1992</year><volume>51</volume><fpage>303</fpage><lpage>311</lpage></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mato</surname><given-names>N</given-names></name><name><surname>Ookara</surname><given-names>S</given-names></name><name><surname>Sakamoto</surname><given-names>A</given-names></name><name><surname>Aikawa</surname><given-names>E</given-names></name><name><surname>Ogawa</surname><given-names>T</given-names></name><name><surname>Mitsuhashi</surname><given-names>U</given-names></name><name><surname>Masuzawa</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Honda</surname><given-names>M</given-names></name><name><surname>Yazaki</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>E</given-names></name><name><surname>Luoma</surname><given-names>J</given-names></name><name><surname>Yla-Herttuala</surname><given-names>S</given-names></name><name><surname>Fraser</surname><given-names>I</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name></person-group><article-title>Involvement of specific macrophage-lineage cell surrounding arterioles in barrier and scavenger function in brain cortex.</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>3269</fpage><lpage>3274</lpage><pub-id pub-id-type="pmid">8622926</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.8.3269</pub-id></citation></ref><ref id="B9"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Angelov</surname><given-names>DN</given-names></name><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Streppel</surname><given-names>M</given-names></name><name><surname>Guntinas-Lichius</surname><given-names>O</given-names></name><name><surname>Neiss</surname><given-names>WF</given-names></name></person-group><article-title>The cerebral perivascular cells.</article-title><source>Advances in Anatomy, Embryology and Cell Biology</source><year>1998</year><volume>147</volume><publisher-name>Springer Verlag Berlin</publisher-name></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Leblond</surname><given-names>CP</given-names></name></person-group><article-title>Identification of microglia in light and electron microscopy.</article-title><source>J Comp Neuol</source><year>1969</year><volume>135</volume><fpage>57</fpage><lpage>80</lpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kida</surname><given-names>S</given-names></name><name><surname>Steart</surname><given-names>PV</given-names></name><name><surname>Zhang</surname><given-names>ET</given-names></name><name><surname>Weller</surname><given-names>RO</given-names></name></person-group><article-title>Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages.</article-title><source>Acta Neuropathol</source><year>1993</year><volume>85</volume><fpage>646</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">8337943</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bechmann</surname><given-names>I</given-names></name><name><surname>Kwidzinski</surname><given-names>E</given-names></name><name><surname>Kovac</surname><given-names>AD</given-names></name><name><surname>Simb&#x000fc;rger</surname><given-names>E</given-names></name><name><surname>Horvath</surname><given-names>T</given-names></name><name><surname>Gimsa</surname><given-names>U</given-names></name><name><surname>Dirnag</surname><given-names>U</given-names></name><name><surname>Priller</surname><given-names>J</given-names></name><name><surname>Nitsch</surname><given-names>R</given-names></name></person-group><article-title>Turnover of rat brain perivascular cells.</article-title><source>Exp Neurol</source><year>2001</year><volume>168</volume><fpage>242</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">11259112</pub-id><pub-id pub-id-type="doi">10.1006/exnr.2000.7618</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dijkstra</surname><given-names>CD</given-names></name><name><surname>Damoiseaux</surname><given-names>JGMC</given-names></name></person-group><article-title>Macrophage heterogeneity established by immunocytochemistry.</article-title><source>Progr Histochem Cytochem</source><year>1993</year><volume>27</volume><fpage>1</fpage><lpage>65</lpage></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graeber</surname><given-names>MM</given-names></name><name><surname>Streit</surname><given-names>WJ</given-names></name><name><surname>Kiefer</surname><given-names>R</given-names></name><name><surname>Schoen</surname><given-names>S</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name></person-group><article-title>New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury.</article-title><source>J Neuroimmunol</source><year>1990</year><volume>27</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">2332482</pub-id><pub-id pub-id-type="doi">10.1016/0165-5728(90)90061-Q</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname><given-names>RO</given-names></name><name><surname>Engelhardt</surname><given-names>B</given-names></name><name><surname>Phillips</surname><given-names>MJ</given-names></name></person-group><article-title>Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways.</article-title><source>Brain Pathol</source><year>1996</year><volume>6</volume><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">8864284</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raine</surname><given-names>CS</given-names></name></person-group><article-title>The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion.</article-title><source>Ann Neurol</source><year>1994</year><volume>36</volume><fpage>S61</fpage><lpage>S72</lpage><pub-id pub-id-type="pmid">8017891</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dijkstra</surname><given-names>CD</given-names></name><name><surname>D&#x000f6;pp</surname><given-names>EA</given-names></name><name><surname>van den Berg</surname><given-names>TK</given-names></name><name><surname>Damoiseaux</surname><given-names>JGMC</given-names></name></person-group><article-title>Monoclonal antibodies against rat macrophages.</article-title><source>J Immunol Methods</source><year>1994</year><volume>174</volume><fpage>21</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">8083524</pub-id><pub-id pub-id-type="doi">10.1016/0022-1759(94)90006-X</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fl&#x000fc;gel</surname><given-names>A</given-names></name><name><surname>Willem</surname><given-names>M</given-names></name><name><surname>Berkowicz</surname><given-names>T</given-names></name><name><surname>Wekerle</surname><given-names>H</given-names></name></person-group><article-title>Gene transfer into CD4<sup>+</sup> T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses.</article-title><source>Nature Medicine</source><year>1999</year><volume>5</volume><fpage>843</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">10395334</pub-id><pub-id pub-id-type="doi">10.1038/10567</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fl&#x000fc;gel</surname><given-names>A</given-names></name><name><surname>Bradl</surname><given-names>M</given-names></name></person-group><article-title>New tools to trace populations of inflammatory cells in the CNS.</article-title><source>Glia</source><year>2001</year><volume>36</volume><fpage>125</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">11596121</pub-id><pub-id pub-id-type="doi">10.1002/glia.1102</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dijkstra</surname><given-names>CD</given-names></name><name><surname>D&#x000f6;pp</surname><given-names>EA</given-names></name><name><surname>Joling</surname><given-names>P</given-names></name><name><surname>Kraal</surname><given-names>G</given-names></name></person-group><article-title>The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.</article-title><source>Immunology</source><year>1985</year><volume>54</volume><fpage>589</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">3882559</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>B</given-names></name><name><surname>Conley</surname><given-names>FK</given-names></name><name><surname>Butcher</surname><given-names>EC</given-names></name></person-group><article-title>Cell-adhesion molecules on vessels during inflammation in the mouse central nervous system</article-title><source>J Neuroimmunol</source><year>1994</year><volume>51</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">7514186</pub-id><pub-id pub-id-type="doi">10.1016/0165-5728(94)90082-5</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>MD</given-names></name><name><surname>Perry</surname><given-names>VH</given-names></name></person-group><article-title>Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammogen or during acute neuronal degeneration</article-title><source>J Neurocytol</source><year>1995</year><volume>24</volume><fpage>695</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">7500124</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>VH</given-names></name><name><surname>Bell</surname><given-names>MD</given-names></name><name><surname>Brown</surname><given-names>HC</given-names></name><name><surname>Matyszak</surname><given-names>MK</given-names></name></person-group><article-title>Inflamation in the nervous system.</article-title><source>Curr Opin Neurobiol</source><year>1995</year><volume>5</volume><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">8580715</pub-id><pub-id pub-id-type="doi">10.1016/0959-4388(95)80069-7</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jander</surname><given-names>S</given-names></name><name><surname>Pohl</surname><given-names>J</given-names></name><name><surname>Gillen</surname><given-names>C</given-names></name><name><surname>Schroeter</surname><given-names>M</given-names></name><name><surname>Stoll</surname><given-names>G</given-names></name></person-group><article-title>Vascular cell adhesion molecule-1 mRNA is expressed in immune-mediated and ischemic injury of the rat nervous system.</article-title><source>J Neuroimmunol</source><year>1996</year><volume>70</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">8862137</pub-id><pub-id pub-id-type="doi">10.1016/S0165-5728(96)00109-9</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Glabinski</surname><given-names>AR</given-names></name><name><surname>Tani</surname><given-names>M</given-names></name></person-group><article-title>Chemokines in immune-mediated inflammation of the central nervous system.</article-title><source>Cytokine and Growth Factor Rev</source><year>1996</year><volume>7</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">8864353</pub-id><pub-id pub-id-type="doi">10.1016/1359-6101(96)00003-2</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Tani</surname><given-names>M</given-names></name><name><surname>Glabinski</surname><given-names>AR</given-names></name><name><surname>Chernosky</surname><given-names>A</given-names></name><name><surname>Krivacic</surname><given-names>K</given-names></name><name><surname>Peterson</surname><given-names>JW</given-names></name><name><surname>Chien</surname><given-names>H-F</given-names></name><name><surname>Trapp</surname><given-names>BD</given-names></name></person-group><article-title>Chemokines and chemokine receptors in model neurological pathologies: Molecular and immunohistochemical approaches.</article-title><source>Methods Enzymol</source><year>1997</year><volume>287</volume><fpage>319</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">9330331</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aloisi</surname><given-names>F</given-names></name></person-group><article-title>Immune function of microglia.</article-title><source>Glia</source><year>2001</year><volume>36</volume><fpage>165</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">11596125</pub-id><pub-id pub-id-type="doi">10.1002/glia.1106</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baggiolini</surname><given-names>M</given-names></name></person-group><article-title>Chemokines in pathology and medicine.</article-title><source>J Intern Med</source><year>2001</year><volume>250</volume><fpage>91</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">11489059</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2796.2001.00867.x</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prat</surname><given-names>A</given-names></name><name><surname>Biernacki</surname><given-names>K</given-names></name><name><surname>Wosik</surname><given-names>K</given-names></name><name><surname>Antel</surname><given-names>JP</given-names></name></person-group><article-title>Glial cell influence on the human blood-brain-barrier.</article-title><source>Glia</source><year>2001</year><volume>36</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11596123</pub-id><pub-id pub-id-type="doi">10.1002/glia.1104</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>CF</given-names></name><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Gelman</surname><given-names>M</given-names></name><name><surname>Mallat</surname><given-names>M</given-names></name></person-group><article-title>Production of Monocyte Chemotactic Protein-1 by rat brain macrophages.</article-title><source>Eur J Neurosci</source><year>1996</year><volume>8</volume><fpage>1725</fpage><lpage>1734</lpage><pub-id pub-id-type="pmid">8921263</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glabinski</surname><given-names>AR</given-names></name><name><surname>Tuohy</surname><given-names>VK</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name></person-group><article-title>Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis.</article-title><source>Neuroimmunomodulation</source><year>1998</year><volume>5</volume><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">9730682</pub-id><pub-id pub-id-type="doi">10.1159/000026333</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rezaie</surname><given-names>P</given-names></name><name><surname>Trillo-Pazos</surname><given-names>G</given-names></name><name><surname>Everall</surname><given-names>IP</given-names></name><name><surname>Male</surname><given-names>DK</given-names></name></person-group><article-title>Expression of &#x003b2;-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS.</article-title><source>Glia</source><year>2002</year><volume>37</volume><fpage>64</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">11746784</pub-id><pub-id pub-id-type="doi">10.1002/glia.1128</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wekerle</surname><given-names>H</given-names></name><name><surname>Linington</surname><given-names>C</given-names></name><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Meyermann</surname><given-names>R</given-names></name></person-group><article-title>Cellular immune reactivity within the CNS.</article-title><source>TINS</source><year>1986</year><volume>9</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/0166-2236(86)90077-9</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>WF</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>Graft-vs-host disease elicits expression of class I and class II hostocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.</article-title><source>Proc Natl Acad Sci USA</source><year>1987</year><volume>84</volume><fpage>2082</fpage><lpage>2086</lpage><pub-id pub-id-type="pmid">3550805</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>PY</given-names></name><name><surname>Day</surname><given-names>ED</given-names></name><name><surname>Whitacre</surname><given-names>CC</given-names></name></person-group><article-title>Neuroimmunologic diseases: Effector cell responses and immunoregulatory mechanisms.</article-title><source>Immunol Rev</source><year>1981</year><volume>55</volume><fpage>89</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">6165674</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raivich</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>LL</given-names></name><name><surname>Kloss</surname><given-names>CUA</given-names></name><name><surname>Werner</surname><given-names>A</given-names></name><name><surname>Neumann</surname><given-names>H</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name></person-group><article-title>Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration.</article-title><source>J Neurosc</source><year>1998</year><volume>18</volume><fpage>5804</fpage><lpage>5816</lpage></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>G</given-names></name><name><surname>Jander</surname><given-names>S</given-names></name></person-group><article-title>The role of microglia and macrophages in the pathophysiology of the CNS.</article-title><source>Progr Neurobiol</source><year>1999</year><volume>58</volume><fpage>233</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">10341362</pub-id><pub-id pub-id-type="doi">10.1016/S0301-0082(98)00083-5</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fl&#x000fc;gel</surname><given-names>A</given-names></name><name><surname>Schwaiger</surname><given-names>F-W</given-names></name><name><surname>Neumann</surname><given-names>H</given-names></name><name><surname>Medana</surname><given-names>I</given-names></name><name><surname>Willem</surname><given-names>M</given-names></name><name><surname>Wekerle</surname><given-names>H</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name><name><surname>Graeber</surname><given-names>MB</given-names></name></person-group><article-title>Neuronal FasL induces cell death of encephalithogenic T lymphocytes.</article-title><source>Brain Pathol</source><year>2000</year><volume>10</volume><fpage>353</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">10885654</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>CF</given-names></name><name><surname>Claudio</surname><given-names>L</given-names></name><name><surname>Tansey</surname><given-names>FA</given-names></name><name><surname>Martiney</surname><given-names>J</given-names></name></person-group><article-title>Mechanism of autoimmune neuropathies.</article-title><source>Ann Neurol</source><year>1990</year><volume>27</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">2137320</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ptak</surname><given-names>W</given-names></name><name><surname>Herzog</surname><given-names>WR</given-names></name><name><surname>Askenase</surname><given-names>PW</given-names></name></person-group><article-title>Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.</article-title><source>J Immunol</source><year>1991</year><volume>146</volume><fpage>469</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">1987274</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Sminia</surname><given-names>T</given-names></name><name><surname>Wouterlood</surname><given-names>FG</given-names></name><name><surname>Dijkstra</surname><given-names>CD</given-names></name></person-group><article-title>Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis.</article-title><source>J Neurosci Res</source><year>1994</year><volume>38</volume><fpage>365</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">7932870</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisniewski</surname><given-names>HM</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name></person-group><article-title>Primary demyelination as a non-specific consequence of a cell-mediated immune reaction.</article-title><source>J Exp Med</source><year>1975</year><volume>141</volume><fpage>346</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">803545</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>B</given-names></name><name><surname>Matyszak</surname><given-names>MK</given-names></name><name><surname>Esiri</surname><given-names>MM</given-names></name><name><surname>Perry</surname><given-names>VH</given-names></name></person-group><article-title>Axonal damage in acute multiple sclerosis lesions.</article-title><source>Brain</source><year>1997</year><volume>120</volume><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">9126051</pub-id><pub-id pub-id-type="doi">10.1093/brain/120.3.393</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trapp</surname><given-names>BD</given-names></name><name><surname>Peterson</surname><given-names>J</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Rudick</surname><given-names>R</given-names></name><name><surname>M&#x000f6;rk</surname><given-names>S</given-names></name><name><surname>B&#x000f6;</surname><given-names>L</given-names></name></person-group><article-title>Axonal transection in the lesions of multiple sclerosis.</article-title><source>N Engl J Med</source><year>1998</year><volume>338</volume><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">9445407</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199801293380502</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiefer</surname><given-names>R</given-names></name><name><surname>Kieseier</surname><given-names>BC</given-names></name><name><surname>Stoll</surname><given-names>G</given-names></name><name><surname>Hartung</surname><given-names>H-P</given-names></name></person-group><article-title>The role of macrophages in the immune-mediated damage to the peripheral nervous system.</article-title><source>Progr Neurobiol</source><year>2001</year><volume>64</volume><fpage>109</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">11240209</pub-id><pub-id pub-id-type="doi">10.1016/S0301-0082(00)00060-5</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>WF</given-names></name><name><surname>Hsu</surname><given-names>BL</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name></person-group><article-title>T-lymphocyte entry into the central nervous system.</article-title><source>J Neurosci Res</source><year>1991</year><volume>28</volume><fpage>254</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">2033653</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Zimprich</surname><given-names>F</given-names></name><name><surname>Vass</surname><given-names>K</given-names></name><name><surname>Hickey</surname><given-names>WF</given-names></name></person-group><article-title>Microglial cells are a component of the perivascular glia limitans.</article-title><source>J Neurosci Res</source><year>1991</year><volume>28</volume><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">2033652</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muhallab</surname><given-names>S</given-names></name><name><surname>Lidman</surname><given-names>O</given-names></name><name><surname>Weissert</surname><given-names>R</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Svenningsson</surname><given-names>A</given-names></name></person-group><article-title>Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.</article-title><source>J Neuroimmunol</source><year>2001</year><volume>113</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/S0165-5728(00)00438-0</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raine</surname><given-names>CS</given-names></name><name><surname>Cannella</surname><given-names>B</given-names></name><name><surname>Duijvestijn</surname><given-names>AM</given-names></name><name><surname>Cross</surname><given-names>AH</given-names></name></person-group><article-title>Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.</article-title><source>Lab Invest</source><year>1990</year><volume>63</volume><fpage>476</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">1700193</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Zimprich</surname><given-names>F</given-names></name><name><surname>R&#x000f6;ssler</surname><given-names>K</given-names></name><name><surname>Vass</surname><given-names>K</given-names></name></person-group><article-title>Inflammation in the nervous system.</article-title><source>Rev Neurol (Paris)</source><year>1991</year><volume>147</volume><fpage>763</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">1780606</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Vass</surname><given-names>K</given-names></name><name><surname>Brunner</surname><given-names>C</given-names></name><name><surname>Seutelberger</surname><given-names>F</given-names></name></person-group><article-title>Characterization of inflammatory infiltrates in experimental allergic encephalomyelitis.</article-title><source>Progr Neuropathol</source><year>1986</year><volume>6</volume><fpage>33</fpage><lpage>62</lpage></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>WF</given-names></name></person-group><article-title>Basic principles of immunological surveillance of the normal central nervous system.</article-title><source>Glia</source><year>2001</year><volume>36</volume><fpage>118</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">11596120</pub-id><pub-id pub-id-type="doi">10.1002/glia.1101</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>AH</given-names></name><name><surname>Cannella</surname><given-names>B</given-names></name><name><surname>Brosnan</surname><given-names>CF</given-names></name><name><surname>Raine</surname><given-names>CS</given-names></name></person-group><article-title>Homing to central nervous system vasculature by antigen specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic and relapsing experimental allergic encephalomyelitis.</article-title><source>Lab Invest</source><year>1990</year><volume>63</volume><fpage>162</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">1696331</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krakowsky</surname><given-names>ML</given-names></name><name><surname>Owens</surname><given-names>T</given-names></name></person-group><article-title>Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation.</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>1002</fpage><lpage>1009</lpage><pub-id pub-id-type="pmid">10760787</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(200004)30:4&#x0003c;1002::AID-IMMU1002&#x0003e;3.0.CO;2-2</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Male</surname><given-names>D</given-names></name><name><surname>Pryce</surname><given-names>G</given-names></name><name><surname>Rahman</surname><given-names>J</given-names></name></person-group><article-title>Comparison of the immunological properties of rat cerebral and aortic endothelium.</article-title><source>J Neuroimmunol</source><year>1990</year><volume>30</volume><fpage>167</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/0165-5728(90)90100-2</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>T</given-names></name><name><surname>Weerth</surname><given-names>S</given-names></name><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Linington</surname><given-names>C</given-names></name><name><surname>Wekerle</surname><given-names>H</given-names></name><name><surname>Lassmann</surname><given-names>H</given-names></name></person-group><article-title>Experimental autoimmune encephalomyelitis: the antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system.</article-title><source>Lab Invest</source><year>1997</year><volume>76</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">9121118</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serpe</surname><given-names>CJ</given-names></name><name><surname>Kohm</surname><given-names>AP</given-names></name><name><surname>Huppenbauer</surname><given-names>CB</given-names></name><name><surname>Sanders</surname><given-names>VM</given-names></name><name><surname>Jones</surname><given-names>KJ</given-names></name></person-group><article-title>Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice.</article-title><source>J Neurosci</source><year>1999</year><volume>19RCN</volume><fpage>1</fpage><lpage>5</lpage></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delves</surname><given-names>PJ</given-names></name><name><surname>Roitt</surname><given-names>IM</given-names></name></person-group><article-title>The immune system.</article-title><source>N Engl J Med</source><year>2000</year><volume>343</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">10882768</pub-id><pub-id pub-id-type="doi">10.1056/NEJM200007063430107</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knopf</surname><given-names>PM</given-names></name><name><surname>Harling-Berg</surname><given-names>CJ</given-names></name><name><surname>Cserr</surname><given-names>HF</given-names></name><name><surname>Basu</surname><given-names>D</given-names></name><name><surname>Sirulnick</surname><given-names>EJ</given-names></name><name><surname>Nolan</surname><given-names>SC</given-names></name><name><surname>Park</surname><given-names>JT</given-names></name><name><surname>Keir</surname><given-names>G</given-names></name><name><surname>Thompson</surname><given-names>EJ</given-names></name><name><surname>Hickey</surname><given-names>WF</given-names></name></person-group><article-title>Antigen-dependent intrathecal synthesis in the normal rat brain: tissue entry and local retention of antigen specific B cells.</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>692</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">9670944</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lassmann</surname><given-names>H</given-names></name></person-group><article-title>Basic mechanisms of brain inflammation.</article-title><source>J Neural Transm Suppl</source><year>1997</year><volume>50</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">9120418</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>JI</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Appel</surname><given-names>SH</given-names></name></person-group><article-title>Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis.</article-title><source>Arch Neurol</source><year>1993</year><volume>50</volume><fpage>30</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">8093428</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamata</surname><given-names>T</given-names></name><name><surname>Akiyama</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>McGeer</surname><given-names>PL</given-names></name></person-group><article-title>Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord.</article-title><source>Am J Pathol</source><year>1992</year><volume>140</volume><fpage>691</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">1347673</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schluesener</surname><given-names>HJ</given-names></name><name><surname>Seid</surname><given-names>K</given-names></name><name><surname>Kretzschmar</surname><given-names>J</given-names></name><name><surname>Meyermann</surname><given-names>R</given-names></name></person-group><article-title>Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque.</article-title><source>J Neurosci Res</source><year>1996</year><volume>44</volume><fpage>606</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">8794952</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19960615)44:6&#x0003c;606::AID-JNR11&#x0003e;3.3.CO;2-L</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>AH</given-names></name><name><surname>O'Mara</surname><given-names>T</given-names></name><name><surname>Raine</surname><given-names>CS</given-names></name></person-group><article-title>Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis.</article-title><source>Neurology</source><year>1993</year><volume>43</volume><fpage>1028</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">7684116</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>K</given-names></name><name><surname>Craig Hooper</surname><given-names>D</given-names></name><name><surname>Bornhorst</surname><given-names>A</given-names></name><name><surname>Corisdeo</surname><given-names>S</given-names></name><name><surname>Bette</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>ZF</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>MK-H</given-names></name><name><surname>Koprowsky</surname><given-names>H</given-names></name><name><surname>Weihe</surname><given-names>E</given-names></name><name><surname>Dietzschold</surname><given-names>B</given-names></name></person-group><article-title>Intrinsic responses to Borna disease virus infection of the central nervous system.</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>13345</fpage><lpage>13350</lpage><pub-id pub-id-type="pmid">8917593</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.23.13345</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Pollard</surname><given-names>J</given-names></name><name><surname>Hunt</surname><given-names>N</given-names></name><name><surname>Chan-Ling</surname><given-names>T</given-names></name></person-group><article-title>Microvascular and cellular responses in the retina of rats with acute experimental allergic encephalomyelitis (EAE).</article-title><source>Brain Pathol</source><year>1998</year><volume>8</volume><fpage>487</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">9669699</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deiniger</surname><given-names>MH</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Schluesener</surname><given-names>HJ</given-names></name></person-group><article-title>CP-10, a chemotactic peptide, is expressed in lesions of experimental autoimmune encephalomyelitis, neuritis, uveitis and in C6 gliomas.</article-title><source>J Neuroimmunol</source><year>1999</year><volume>93</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">10378879</pub-id><pub-id pub-id-type="doi">10.1016/S0165-5728(98)00221-5</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raivich</surname><given-names>G</given-names></name><name><surname>Bohatscheck</surname><given-names>M</given-names></name><name><surname>Kloss</surname><given-names>CUA</given-names></name><name><surname>Werner</surname><given-names>A</given-names></name><name><surname>Neumann</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>LL</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name></person-group><article-title>Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function.</article-title><source>Brain Res Rev</source><year>1999</year><volume>30</volume><fpage>77</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">10407127</pub-id><pub-id pub-id-type="doi">10.1016/S0165-0173(99)00007-7</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>JM</given-names></name><name><surname>Morris</surname><given-names>RJ</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name><name><surname>Raisman</surname><given-names>G</given-names></name></person-group><article-title>Mechanisms of allograft rejection in the rat brain.</article-title><source>Neuroscience</source><year>1990</year><volume>37</volume><fpage>431</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">2133352</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(90)90413-X</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Angelov</surname><given-names>DN</given-names></name><name><surname>Neiss</surname><given-names>WF</given-names></name><name><surname>Streppel</surname><given-names>M</given-names></name><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Guntinas-Lichius</surname><given-names>O</given-names></name><name><surname>Stennert</surname><given-names>E</given-names></name></person-group><article-title>ED2-positive perivascular cells act as neuronophages during delayed neuronal loss in the facial nucleus of the rat.</article-title><source>Glia</source><year>1996</year><volume>16</volume><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">8929900</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1098-1136(199602)16:2&#x0003c;129::AID-GLIA5&#x0003e;3.3.CO;2-D</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Angelov</surname><given-names>DN</given-names></name><name><surname>Streppel</surname><given-names>M</given-names></name><name><surname>Walther</surname><given-names>M</given-names></name><name><surname>Guntinas-Lichius</surname><given-names>O</given-names></name><name><surname>van Dam</surname><given-names>AM</given-names></name><name><surname>Stennert</surname><given-names>E</given-names></name><name><surname>Neiss</surname><given-names>WF</given-names></name></person-group><article-title>ED2-positive perivascular neuronophages produce Interleukin-1&#x003b2; during delayed neuronal loss in the facial nucleus of the rat.</article-title><source>J Neurosci Res</source><year>1998</year><volume>54</volume><fpage>820</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">9856866</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19981215)54:6&#x0003c;820::AID-JNR10&#x0003e;3.0.CO;2-X</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>KC</given-names></name><name><surname>Corey</surname><given-names>S</given-names></name><name><surname>Westmoreland</surname><given-names>SV</given-names></name><name><surname>Pauley</surname><given-names>D</given-names></name><name><surname>Knight</surname><given-names>H</given-names></name><name><surname>deBakker</surname><given-names>C</given-names></name><name><surname>Alvarez</surname><given-names>X</given-names></name><name><surname>Lackner</surname><given-names>AA</given-names></name></person-group><article-title>Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.</article-title><source>J Exp Med</source><year>2001</year><volume>193</volume><fpage>905</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">11304551</pub-id><pub-id pub-id-type="doi">10.1084/jem.193.8.905</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMenamin</surname><given-names>PG</given-names></name></person-group><article-title>Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations.</article-title><source>J Comp Neurol</source><year>1999</year><volume>405</volume><fpage>553</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">10098945</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19990322)405:4&#x0003c;553::AID-CNE8&#x0003e;3.3.CO;2-Y</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grakoui</surname><given-names>A</given-names></name><name><surname>Bromley</surname><given-names>SK</given-names></name><name><surname>Sumen</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name><name><surname>Shaw</surname><given-names>AS</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Dustin</surname><given-names>ML</given-names></name></person-group><article-title>The immunological synapse: a molecular machine controlling T cell activation.</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>207</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">10428718</pub-id><pub-id pub-id-type="doi">10.1126/science.285.5425.221</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Hara</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>R</given-names></name><name><surname>Fujihara</surname><given-names>M</given-names></name></person-group><article-title>Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.</article-title><source>J Neuroimmunol</source><year>1986</year><volume>136</volume><fpage>3668</fpage><lpage>3676</lpage></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Litzenburger</surname><given-names>T</given-names></name><name><surname>F&#x000e4;ssler</surname><given-names>R</given-names></name><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Linington</surname><given-names>C</given-names></name><name><surname>Wekerle</surname><given-names>H</given-names></name><name><surname>Iglesias</surname><given-names>A</given-names></name></person-group><article-title>B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">9653093</pub-id><pub-id pub-id-type="doi">10.1084/jem.188.1.169</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>AH</given-names></name><name><surname>Trotter</surname><given-names>JL</given-names></name><name><surname>Lyons</surname><given-names>J-A</given-names></name></person-group><article-title>B cells and antibodies in CNS demyelinating disease.</article-title><source>J Neuroimmunol</source><year>2001</year><volume>112</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11108928</pub-id><pub-id pub-id-type="doi">10.1016/S0165-5728(00)00409-4</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>AM</given-names></name><name><surname>Glynn</surname><given-names>P</given-names></name></person-group><article-title>Lewis rat lymphoid dendritic cells can efficiently present homologous myelin basic protein to encephalitogenic lymphocytes.</article-title><source>J Neuroimmunol</source><year>1989</year><volume>22</volume><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">2466870</pub-id><pub-id pub-id-type="doi">10.1016/0165-5728(89)90041-6</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Resch</surname><given-names>K</given-names></name></person-group><article-title>Interleukin 1: more than a mediator between leukocytes.</article-title><source>TINS</source><year>1988</year><volume>9</volume><fpage>171</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/0165-6147(88)90033-8</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>M</given-names></name><name><surname>Dubey</surname><given-names>C</given-names></name></person-group><article-title>Accessory molecule and costimulation requirements for CD4 T cell response.</article-title><source>Crit Rev Immunol</source><year>1997</year><volume>17</volume><fpage>89</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">9034725</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Wekerle</surname><given-names>H</given-names></name></person-group><article-title>Ia restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.</article-title><source>Nature</source><year>1986</year><volume>320</volume><fpage>70</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">2419764</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Ohmori</surname><given-names>J</given-names></name><name><surname>Fujihara</surname><given-names>M</given-names></name></person-group><article-title>Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T-cells under in vivo mimicking conditions.</article-title><source>Immunology</source><year>1992</year><volume>76</volume><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">1378815</pub-id></citation></ref><ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>CF</given-names></name><name><surname>Raine</surname><given-names>CS</given-names></name></person-group><article-title>Mechanisms of immune injury in multiple sclerosis.</article-title><source>Brain Pathol</source><year>1996</year><volume>6</volume><fpage>243</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">8864282</pub-id></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>C</given-names></name><name><surname>Bornstein</surname><given-names>MB</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name></person-group><article-title>The effect of macrophage depletion on clinical and pathological expression of experimental allergic encephalomyelitis.</article-title><source>J Immunol</source><year>1981</year><volume>126</volume><fpage>614</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">6256443</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Huitinga</surname><given-names>I</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Hickey</surname><given-names>W</given-names></name><name><surname>Dijkstra</surname><given-names>CD</given-names></name></person-group><article-title>The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis.</article-title><source>Glia</source><year>1995</year><volume>15</volume><fpage>437</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">8926037</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huitinga</surname><given-names>I</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><name><surname>de Groot</surname><given-names>CJA</given-names></name><name><surname>Uitdehaag</surname><given-names>BMJ</given-names></name><name><surname>Dikstra</surname><given-names>CD</given-names></name></person-group><article-title>Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.</article-title><source>J Exp Med</source><year>1990</year><volume>172</volume><fpage>1025</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">2145387</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huitinga</surname><given-names>I</given-names></name><name><surname>Ruuls</surname><given-names>SR</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><name><surname>Hartung</surname><given-names>H-P</given-names></name><name><surname>Dikstra</surname><given-names>CD</given-names></name></person-group><article-title>Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewin rats.</article-title><source>Clin Exp Immunol</source><year>1995</year><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">7743675</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>EH</given-names></name><name><surname>Hoekstra</surname><given-names>K</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><name><surname>Dijkstra</surname><given-names>CD</given-names></name><name><surname>Owens</surname><given-names>T</given-names></name></person-group><article-title>Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage depleted mice.</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>3767</fpage><lpage>3775</lpage><pub-id pub-id-type="pmid">9759903</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polfliet</surname><given-names>MMJ</given-names></name><name><surname>van de Veerdonk</surname><given-names>F</given-names></name><name><surname>D&#x000f6;pp</surname><given-names>E</given-names></name><name><surname>van Kesteren-Hendrikx</surname><given-names>EM</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><name><surname>Dijkstra</surname><given-names>CD</given-names></name><name><surname>van der Berg</surname><given-names>T</given-names></name></person-group><article-title>The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis.</article-title><source>J Neuroimmunol</source><year>2002</year><volume>122</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11777538</pub-id><pub-id pub-id-type="doi">10.1016/S0165-5728(01)00445-3</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>HJ</given-names></name><name><surname>Pilgrim</surname><given-names>C</given-names></name><name><surname>Brandl</surname><given-names>J</given-names></name></person-group><article-title>Penetration and removal of horseradish peroxidase injected into the cerebrospinal fluid: role of cerebral perivascular spaces, endothelium and microglia.</article-title><source>Acta Neuropathol</source><year>1974</year><volume>27</volume><fpage>299</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">4366438</pub-id></citation></ref><ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mingheti</surname><given-names>L</given-names></name><name><surname>Walsh</surname><given-names>DT</given-names></name><name><surname>Levi</surname><given-names>G</given-names></name><name><surname>Perry</surname><given-names>VH</given-names></name></person-group><article-title>In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines.</article-title><source>J Neuropathol Exp Neurol</source><year>1999</year><volume>58</volume><fpage>1184</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">10560661</pub-id></citation></ref><ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>IW</given-names></name><name><surname>Nakane</surname><given-names>PK</given-names></name></person-group><article-title>Periodate-lysine-paraformaldehyde fixative a new fixative for immunoelectron microscopy.</article-title><source>J Histochem Cytochem</source><year>1974</year><volume>22</volume><fpage>1077</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">4374474</pub-id></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langford</surname><given-names>LA</given-names></name><name><surname>Coggeshall</surname><given-names>RE</given-names></name></person-group><article-title>The use of potassium ferricyanide in neural fixation.</article-title><source>Anat Rec</source><year>1980</year><volume>197</volume><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">6776846</pub-id></citation></ref></ref-list></back></article> 